Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.
Ntanasis-Stathopoulos I, Bagratuni T, Gavriatopoulou M, Patseas D, Liacos C, Kanellias N, Fotiou D, Tsiligkeridou E, Andreatou A, Mavrianou-Koutsoukou N, Migkou M, Eleutherakis-Papaiakovou E, Roussou M, Terpos E, Kastritis E, Dimopoulos MA. Ntanasis-Stathopoulos I, et al. Among authors: dimopoulos ma. Am J Hematol. 2020 Jun;95(6):E148-E150. doi: 10.1002/ajh.25802. Epub 2020 Apr 15. Am J Hematol. 2020. PMID: 32242972 Free article. No abstract available.
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.
Bagratuni T, Ntanasis-Stathopoulos I, Gavriatopoulou M, Mavrianou-Koutsoukou N, Liacos C, Patseas D, Kanellias N, Migkou M, Ziogas DC, Eleutherakis-Papaiakovou E, Roussou M, Fotiou D, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: dimopoulos ma. Leukemia. 2018 Dec;32(12):2617-2625. doi: 10.1038/s41375-018-0197-7. Epub 2018 Jul 19. Leukemia. 2018. PMID: 30026568 Free PMC article.
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Bagratuni T, Markou A, Patseas D, Mavrianou-Koutsoukou N, Aktypi F, Liacos CI, Sklirou AD, Theodorakakou F, Ntanasis-Stathopoulos I, Gavriatopoulou M, Trougakos IP, Lianidou E, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: dimopoulos ma. Blood Adv. 2022 Jan 11;6(1):189-199. doi: 10.1182/bloodadvances.2021005354. Blood Adv. 2022. PMID: 34788399 Free PMC article.
Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E, Fotiou D, Kastritis E, Dimopoulos MA. Ntanasis-Stathopoulos I, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e905-e909. doi: 10.1016/j.clml.2020.06.025. Epub 2020 Jul 4. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32723621
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Eleutherakis-Papaiakovou E, Kostis E, Migkou M, Christoulas D, Terpos E, Gavriatopoulou M, Roussou M, Bournakis E, Kastritis E, Efstathiou E, Dimopoulos MA, Papadimitriou CA. Eleutherakis-Papaiakovou E, et al. Among authors: dimopoulos ma. Am J Hematol. 2010 Nov;85(11):863-7. doi: 10.1002/ajh.21855. Am J Hematol. 2010. PMID: 20882526 Free article. Clinical Trial.
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.
Tasidou A, Roussou M, Terpos E, Kastritis E, Gkotzamanidou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E, Nikitas N, Anagnostou D, Dimopoulos MA. Tasidou A, et al. Among authors: dimopoulos ma. Am J Hematol. 2012 Jul;87(7):734-6. doi: 10.1002/ajh.23223. Epub 2012 May 6. Am J Hematol. 2012. PMID: 22565393 Free article.
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M, Koureas A, Migkou M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Gika D, Koutoulidis V, Terpos E. Moulopoulos LA, et al. Among authors: dimopoulos ma. Am J Hematol. 2012 Sep;87(9):861-4. doi: 10.1002/ajh.23258. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641455 Free article.
Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.
Kastritis E, Roussou M, Gavriatopoulou M, Migkou M, Kalapanida D, Pamboucas C, Kaldara E, Ntalianis A, Psimenou E, Toumanidis ST, Tasidou A, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Am J Hematol. 2015 Apr;90(4):E60-5. doi: 10.1002/ajh.23936. Epub 2015 Mar 9. Am J Hematol. 2015. PMID: 25580702 Free article.
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Eleutherakis-Papaiakovou E, Migkou M, Matsouka C, Mparmparousi D, Gika D, Kafantari E, Ziogas D, Fotiou D, Panagiotidis I, Terpos E, Kastritis E. Dimopoulos MA, et al. Am J Hematol. 2016 May;91(5):499-502. doi: 10.1002/ajh.24335. Epub 2016 Apr 4. Am J Hematol. 2016. PMID: 26890495 Free article. Clinical Trial.
1,275 results